A prediction market on Manifold shows a 96.54% probability that Tesla will announce a formal partnership with Intel for...
A prediction market on Manifold shows a 96.54% probability that Tesla will announce a formal partnership with Intel for an AI chip fab by June 30, 2026 source. This would be a significant validation for Intel's foundry business, potentially impacting the AI chip supply chain. If realized, it could shift some AI chip manufacturing from TSMC to Intel and strengthen Intel's competitive position. However, the high probability is based on a single prediction market, so confidence remains low. What the sources said: The prediction market description states: 'Tesla announces formal Intel partnership for AI chip fab by June 30, 2026.'
confidence score
Strong evidence: 1 independent source class support this read.
INTC is already up +139% over the recent 30-90 day window.
signal brief
A prediction market on Manifold shows a 96.54% probability that Tesla will announce a formal partnership with Intel for an AI chip fab by June 30, 2026 source. This would be a significant validation for Intel's foundry business, potentially impacting the AI chip supply chain. If realized, it could shift some AI chip manufacturing from TSMC to Intel and strengthen Intel's competitive position. However, the high probability is based on a single prediction market, so confidence remains low.
What the sources said: The prediction market description states: 'Tesla announces formal Intel partnership for AI chip fab by June 30, 2026.'
source data used
“Manifold consensus on 'Will Intel manufacture NVIDIA chips by the end of 2026?': YES=27.00%”
“Manifold consensus on 'Tesla announces formal Intel partnership for AI chip fab by June 30, 2026': YES=96.54%”
“Manifold consensus on 'Will there be a joint venture chip foundry between TSMC and Intel? 🇺🇸🦾🤖💻': YES=48.73%”
“Manifold consensus on 'Will Intel's lithography catch up with TSMC by 2028?': YES=14.03%”
spillover entities
Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.